Google News

BIMZELX® (bimekizumab-bkzx) Three-Year Rheumatology Data at ACR 2025 Demonstrated Sustained Inflammation Control in Psoriatic Arthritis and Axial …

BIMZELX[®] (bimekizumab-bkzx) three year rheumatology data at ACR 2025 demonstrated sustained inflammation control in psoriatic arthritis and axial …

We used the keywords “DMARDs OR anti-rheumatic medications”, “foot and ankle surgery OR osteotomy”, AND “Bone healing OR bone union”.

To help guide attendees of all experience levels, Healio Rheumatology asked members of its Peer Perspective Board the following questions:

Rheumatologists are medical doctors who specialise in diagnosing and treating diseases that affect the joints, muscles and bones.

Lujayn Akbar, Rheumatology & Autoimmunity, 2022. Investigation of mechanical failure performance of a large-diameter shield tunnel segmental ring.

References. 1. Miyamoto, ST ∙ Valim, V ∙ Fisher, BA. Health-related quality of life and costs in Sjögren’s syndrome. Rheumatology

… Rheumatology. 22nd. October. Psoriatic Arthritis Shows Lower Cardiorespiratory Fitness Levels. More articles. Rheumatology. 3 Mins. 17 Sep 2025 …

Background: Non-rheumatic valvular heart disease (NRVHD), driven by aging populations and epidemiological transitions, has become the dominant …

Then, following a rheumatology and respiratory MDT, she was commenced on treatment for lupus pneumonitis with high-dose intravenous methylprednisolone …

… (PsA) will be presented as a late breaking poster presentation at the American College of Rheumatology (ACR) Convergence 2025,

Exagen Announces Acceptance of Six Abstracts at 2025 American College of Rheumatology Convergence · Plenary Talk: Monday, October 27, 2025

… health through physical activity. The event, organized with rheumatology and orthopedic associations, emphasized prevention for people over 50.

HealthDay News — Sodium-glucose cotransporter-2 (SGLT-2) inhibitors are associated with a reduced risk for autoimmune rheumatic diseases compared …

Artificial intelligence (AI) could soon help rheumatologists tailor treatment decisions for patients with psoriatic arthritis (PsA) and axial …

Rheumatology Advisor interviewed Edith Williams, MS, PhD, on the topic of promoting diversity in clinical trials.

Spyre Therapeutics Announces Poster Presentations at American College of Rheumatology (ACR) Convergence 2025. Spyre Therapeutics, Inc. Fri, October 24 …

Spyre Therapeutics Announces Poster Presentations at American College of Rheumatology (ACR) … … rheumatic diseases, today announced scientific …

A hypnotic prescribing audit achieved compliance with 14-day maximum durations across all sites, while disease-modifying anti-rheumatic drug (DMARD) …

Orna Therapeutics Announces Encore Presentation at the American College of Rheumatology Annual Meeting Supporting its in vivo CAR Therapy Approach

Spyre Therapeutics Announces Poster Presentations at American College of Rheumatology (ACR) Convergence 2025 … rheumatic diseases, today …

Department of Rheumatology and Immunology, The First People’s Hospital Of Guiyang, Guiyang, 550001, China. Xin Cai, Zexu Jin & Jiajun

… Rheumatology (ACR) Convergence 2025 meeting in Chicago, October 24-29. Sobi is presenting a total of 15 scientific abstracts, with

… Rheumatology. Thomas Wainwright, PhD, PT, professor of orthopedics at Bournemouth University, in the United Kingdom, and colleagues conducted the …

As we approach the American College of Rheumatology (ACR) Convergence 2025, Jeff Stark, MD, US Head of Medical Immunology at

Lilla Gunkl-Tóth, a PhD student at Semmelweis University’s Department of Rheumatology and Immunology, conducted a comprehensive study of patients with …

PMR is an inflammatory rheumatic disease that commonly affects adults aged 50 years and older and is characterized by acute